<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>2</IssueIDStart>
          <IssueIDEnd>2</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>6</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art13">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>72374</ArticleID>
            <ArticleDOI>10.1208/aapsj070238</ArticleDOI>
            <ArticleSequenceNumber>13</ArticleSequenceNumber>
            <ArticleTitle Language="En">On some “disadvantages” of the population approach</ArticleTitle>
            <ArticleFirstPage>E374</ArticleFirstPage>
            <ArticleLastPage>E382</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2005</Year>
                <Month>4</Month>
                <Day>4</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>4</Month>
                <Day>28</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>2</IssueIDStart>
              <IssueIDEnd>2</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jerry</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Nedelman</FamilyName>
                  <Degrees>PhD</Degrees>
                </AuthorName>
                <Role>Director</Role>
                <Contact>
                  <Phone>(862) 778-6730</Phone>
                  <Fax>(973) 781-6498</Fax>
                  <Email>jerry.nedelman@pharma.novartis.com</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Biostatistics and Statistical Programming</OrgDivision>
                <OrgName>Novartis Pharmaceuticals</OrgName>
                <OrgAddress>
                  <Street>One Health Plaza</Street>
                  <Postcode>07936</Postcode>
                  <City>East Hanover</City>
                  <State>NJ</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>In a seminal article on population pharmacokinetic modeling, researchers demonstrated how means and variances of pharmacokinetic parameters for a patient population could be inferred from sparse data collected under conditions of routine patient care. But they also identified 4 potential concerns about their methodology: unobserved confounding variables may bias the inferences; conditions under which data are collected may lead to inaccuracies of reporting or recording; correlations among important predictor variables may reduce statistical efficiency; and costs cannot be controlled by principles of study design. Experiences are reviewed that related to those potential disadvantages. A method is presented for diagnosing the possible presence of confounding. A model is constructed and applied that captures the influences of data inaccuracies. An example of selecting from among correlated covariates is summarized. Finally, a methodology for optimal study design is reviewed and applied to an example.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>optimal design</Keyword>
              <Keyword>variable selection</Keyword>
              <Keyword>noncompliance</Keyword>
              <Keyword>errors in variables</Keyword>
              <Keyword>confounding</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: October 5, 2005</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_72374.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LB</Initials>
                    <FamilyName>Sheiner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Rosenberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VV</Initials>
                    <FamilyName>Marathe</FamilyName>
                  </BibAuthorName>
                  <Year>1977</Year>
                  <ArticleTitle Language="En">Estimation of population characteristics of pharmacokinetic parameters from routine clinical data</ArticleTitle>
                  <JournalTitle>J Pharmacokinet Biopharm.</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>445</FirstPage>
                  <LastPage>479</LastPage>
                  <Occurrence Type="PID">
                    <Handle>925881</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF01061728</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE1cXksVOiuw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.<Emphasis Type="Italic">J Pharmacokinet Biopharm.</Emphasis> 1977;5:445–479.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LB</Initials>
                    <FamilyName>Sheiner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Rosenberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Melmon</FamilyName>
                  </BibAuthorName>
                  <Year>1972</Year>
                  <ArticleTitle Language="En">Modelling of individual pharmacolinetics for computer-aided drug dosage</ArticleTitle>
                  <JournalTitle>Comput Biomed Res.</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>411</FirstPage>
                  <LastPage>459</LastPage>
                  <Occurrence Type="PID">
                    <Handle>4634367</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0010-4809(72)90051-1</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaE3s%2FksVarug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sheiner LB, Rosenberg B, Melmon KL. Modelling of individual pharmacolinetics for computer-aided drug dosage.<Emphasis Type="Italic">Comput Biomed Res.</Emphasis> 1972;5:411–459.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Mentre'</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Burtin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Merle'</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Bree</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Mallet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J-L</Initials>
                    <FamilyName>Steimer</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Sparse-sampling optimal designs in pharmacokinetics and toxicokinetics</ArticleTitle>
                  <JournalTitle>Drug Inf. J</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>997</FirstPage>
                  <LastPage>1019</LastPage>
<Occurrence Type="DOI">
<Handle>10.1177/009286159502900321</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Mentre' F, Burtin P, Merle' Y, van Bree J, Mallet A, Steimer J-L. Sparse-sampling optimal designs in pharmacokinetics and toxicokinetics.<Emphasis Type="Italic">Drug Inf. J</Emphasis> 1995;29:997–1019.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibBook>
                  <BibEditorName>
                    <Initials>SL</Initials>
                    <FamilyName>Beal</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>LB</Initials>
                    <FamilyName>Sheiner</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <Year>1989</Year>
                  <BookTitle>NONMEM Users Guides</BookTitle>
                  <PublisherName>GloboMax, LLC</PublisherName>
                  <PublisherLocation>Hanover, MD</PublisherLocation>
                </BibBook>
                <BibUnstructured>Beal SL, Sheiner LB, eds. NONMEM Users Guides. Hanover, MD: GloboMax, LLC; 1989-1998.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibUnstructured>Available at: http://www.uq.edu.au/pharmacy/sduffull/popt.htm. Accessed date: July 19, 2005.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Retout</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Duffull</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Mentre'</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs</ArticleTitle>
                  <JournalTitle>Comput Methods Programs Biomed.</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>141</FirstPage>
                  <LastPage>151</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11275334</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-2607(00)00117-6</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3M7os12htA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Retout S, Duffull S, Mentre' F. Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs.<Emphasis Type="Italic">Comput Methods Programs Biomed.</Emphasis> 2001;65:141–151.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Retout</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Mentre'</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics</ArticleTitle>
                  <JournalTitle>J Biopharm Stat.</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>209</FirstPage>
                  <LastPage>227</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12729390</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1081/BIP-120019267</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Retout S, Mentre' F. Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics.<Emphasis Type="Italic">J Biopharm Stat.</Emphasis> 2003;13:209–227.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Retout</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Mentre'</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Optimisation of individual and population designs using Splus</ArticleTitle>
                  <JournalTitle>J Pharmacokinet Pharmacodyn.</JournalTitle>
                  <VolumeID>30</VolumeID>
                  <FirstPage>417</FirstPage>
                  <LastPage>453</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15000423</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/B:JOPA.0000013000.59346.9a</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Retout S, Mentre' F. Optimisation of individual and population designs using Splus.<Emphasis Type="Italic">J Pharmacokinet Pharmacodyn.</Emphasis> 2003;30:417–453.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Green</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SB</Initials>
                    <FamilyName>Duffull</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Prospective evaluation of a D-optimal designed population pharmacokinetic study</ArticleTitle>
                  <JournalTitle>J Pharmacokinet Pharmacodyn.</JournalTitle>
                  <VolumeID>30</VolumeID>
                  <FirstPage>145</FirstPage>
                  <LastPage>161</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12942685</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1024467714170</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXms1yhtLs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Green B, Duffull SB. Prospective evaluation of a D-optimal designed population pharmacokinetic study.<Emphasis Type="Italic">J Pharmacokinet Pharmacodyn.</Emphasis> 2003;30:145–161.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Harrel</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <BookTitle>Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival</BookTitle>
                  <PublisherName>Springer</PublisherName>
                  <PublisherLocation>New York</PublisherLocation>
                  <FirstPage>56</FirstPage>
                  <LastPage>60</LastPage>
                </BibBook>
                <BibUnstructured>Harrel F. Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival. New York: Springer, 2001;56–60.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Mandema</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Verotta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LB</Initials>
                    <FamilyName>Sheiner</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Building population pharmacokinetic-pharmacodynamic models. I. Models for covariate effects</ArticleTitle>
                  <JournalTitle>J Pharmacokinet Biopharm.</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>511</FirstPage>
                  <LastPage>528</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1287200</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF01061469</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3s7msVWhsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mandema JW, Verotta D, Sheiner LB. Building population pharmacokinetic-pharmacodynamic models. I. Models for covariate effects.<Emphasis Type="Italic">J Pharmacokinet Biopharm.</Emphasis> 1992;20:511–528.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EN</Initials>
                    <FamilyName>Jonsson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MO</Initials>
                    <FamilyName>Karlsson</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Automated covariate model building with NONMEM</ArticleTitle>
                  <JournalTitle>Pharm. Res.</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>1463</FirstPage>
                  <LastPage>1468</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9755901</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1011970125687</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXmtFyhu7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jonsson EN, Karlsson MO. Automated covariate model building with NONMEM.<Emphasis Type="Italic">Pharm. Res.</Emphasis> 1998;15:1463–1468.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KG</Initials>
                    <FamilyName>Kowalski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Huntmacher</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Efficient screening of covariates in population models using Wald's approximation to the likelihood ratio test</ArticleTitle>
                  <JournalTitle>J Pharmacokinet Pharmacodyn.</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>253</FirstPage>
                  <LastPage>275</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11468940</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1011579109640</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD38%2FitlOktQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kowalski KG, Huntmacher MM. Efficient screening of covariates in population models using Wald's approximation to the likelihood ratio test.<Emphasis Type="Italic">J Pharmacokinet Pharmacodyn.</Emphasis> 2001;28:253–275.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibUnstructured>Available at: http://www.cognigencorp.com/nonmem/nm/ 99sep 152004.html. Accessed date.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibUnstructured>Available at: http://www.cognigencorp.com/nonmen/nm/ 99nov212000.html.Accessed date.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DW</Initials>
                    <FamilyName>Cockroft</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MH</Initials>
                    <FamilyName>Gault</FamilyName>
                  </BibAuthorName>
                  <Year>1976</Year>
                  <ArticleTitle Language="En">Prediction of creatinine clearance from serum creatinine</ArticleTitle>
                  <JournalTitle>Nephron.</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>31</FirstPage>
                  <LastPage>42</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1159/000180580</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine.<Emphasis Type="Italic">Nephron.</Emphasis> 1976;16:31–42.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Girard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LB</Initials>
                    <FamilyName>Sheiner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Kastrissios</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TF</Initials>
                    <FamilyName>Blaschke</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Do we need full compliance data for population pharmacokinetic analysis?</ArticleTitle>
                  <JournalTitle>J Pharmacokinet Biopharm.</JournalTitle>
                  <VolumeID>24</VolumeID>
                  <FirstPage>265</FirstPage>
                  <LastPage>282</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8970015</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF02353671</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXjtFKhtg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Girard P, Sheiner LB, Kastrissios H, Blaschke TF. Do we need full compliance data for population pharmacokinetic analysis?<Emphasis Type="Italic">J Pharmacokinet Biopharm.</Emphasis> 1996;24:265–282.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Vrijens</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Goetghebeur</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">The impact of compliance in pharmacokinetic studies</ArticleTitle>
                  <JournalTitle>Stat Methods Med Res.</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>247</FirstPage>
                  <LastPage>262</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10636337</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1191/096228099669221405</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3c7gtVaqsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Vrijens B, Goetghebeur E. The impact of compliance in pharmacokinetic studies.<Emphasis Type="Italic">Stat Methods Med Res.</Emphasis> 1999;8:247–262.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Vrijens</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Goetghebeur</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Electronic monitoring of variation in drug intakes can reduce bias and improve precision in pharmacokinetic/pharmacodynamic population studies</ArticleTitle>
                  <JournalTitle>Stat Med.</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>531</FirstPage>
                  <LastPage>544</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14755387</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/sim.1619</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Vrijens B, Goetghebeur E. Electronic monitoring of variation in drug intakes can reduce bias and improve precision in pharmacokinetic/pharmacodynamic population studies.<Emphasis Type="Italic">Stat Med.</Emphasis> 2004;23:531–544.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J-M</Initials>
                    <FamilyName>Gries</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Verotta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LB</Initials>
                    <FamilyName>Sheiner</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of noncompliance</ArticleTitle>
                  <JournalTitle>J Pharmacokinet Pharmacodyn.</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>343</FirstPage>
                  <LastPage>362</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11677931</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1011582713692</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXot1GjsLw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lu J, Gries J-M, Verotta D, Sheiner LB. Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of noncompliance.<Emphasis Type="Italic">J Pharmacokinet Pharmacodyn.</Emphasis> 2001;28:343–362.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Mu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TM</Initials>
                    <FamilyName>Ludden</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Estimation of population pharmacokinetic parameters in the presence of non-compliance</ArticleTitle>
                  <JournalTitle>J Pharmacokinet Pharmacodyn.</JournalTitle>
                  <VolumeID>30</VolumeID>
                  <FirstPage>53</FirstPage>
                  <LastPage>81</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12800807</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1023297426153</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mu S, Ludden TM. Estimation of population pharmacokinetic parameters in the presence of non-compliance.<Emphasis Type="Italic">J Pharmacokinet Pharmacodyn.</Emphasis>. 2003;30:53–81.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MO</Initials>
                    <FamilyName>Karlsson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LB</Initials>
                    <FamilyName>Sheiner</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">The importance of modeling interoccasion variability in population pharmacokinetic analyses</ArticleTitle>
                  <JournalTitle>J Pharmacokinet Biopharm.</JournalTitle>
                  <VolumeID>21</VolumeID>
                  <FirstPage>735</FirstPage>
                  <LastPage>750</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8138894</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF01113502</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2c7os12huw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Karlsson MO, Sheiner LB. The importance of modeling interoccasion variability in population pharmacokinetic analyses.<Emphasis Type="Italic">J Pharmacokinet Biopharm.</Emphasis> 1993;21:735–750.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Wang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Hsuan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S-C</Initials>
                    <FamilyName>Chow</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">The impact of patient compliance on drug concentration profile in multiple doses</ArticleTitle>
                  <JournalTitle>Stat Med.</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>659</FirstPage>
                  <LastPage>669</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8731007</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/(SICI)1097-0258(19960330)15:6&lt;659::AID-SIM207&gt;3.0.CO;2-E</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK283psVWhug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wang W, Hsuan F, Chow S-C. The impact of patient compliance on drug concentration profile in multiple doses.<Emphasis Type="Italic">Stat Med.</Emphasis> 1996;15:659–669.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Kendall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Stuart</FamilyName>
                  </BibAuthorName>
                  <Year>1979</Year>
                  <BookTitle>The Advanced Theory of Statistics, Volume 2, Inference and Relationship</BookTitle>
                  <EditionNumber>Fourth Edition</EditionNumber>
                  <PublisherName>Macmillan</PublisherName>
                  <PublisherLocation>New York</PublisherLocation>
                  <FirstPage>400</FirstPage>
                  <LastPage>407</LastPage>
                </BibBook>
                <BibUnstructured>Kendall M, Stuart A. The Advanced Theory of Statistics, Volume 2, Inference and Relationship, Fourth Edition. New York: Macmillan, 1979:400–407.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Soy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Beal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LB</Initials>
                    <FamilyName>Sheiner</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Population one-compartment pharmacokinetic analysis with missing dosage data</ArticleTitle>
                  <JournalTitle>Clin Pharmacol Ther.</JournalTitle>
                  <VolumeID>76</VolumeID>
                  <FirstPage>441</FirstPage>
                  <LastPage>451</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15536459</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.clpt.2004.07.010</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXpslWnt7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Soy D, Beal SL, Sheiner LB. Population one-compartment pharmacokinetic analysis with missing dosage data.<Emphasis Type="Italic">Clin Pharmacol Ther.</Emphasis> 2004;76:441–451.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Sanathanan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CC</Initials>
                    <FamilyName>Peck</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">The randomized concentration-controlled trial: an evaluation of its sample size efficiency</ArticleTitle>
                  <JournalTitle>Control Clin Trials.</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>780</FirstPage>
                  <LastPage>794</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1665119</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0197-2456(91)90041-J</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK387msVentw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sanathanan LP, Peck CC. The randomized concentration-controlled trial: an evaluation of its sample size efficiency.<Emphasis Type="Italic">Control Clin Trials.</Emphasis> 1991;12:780–794.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Hausman</FamilyName>
                  </BibAuthorName>
                  <Year>1983</Year>
                  <ChapterTitle Language="En">Instrumental variable estimation</ChapterTitle>
                  <BibEditorName>
                    <Initials>S</Initials>
                    <FamilyName>Kotz</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>NI</Initials>
                    <FamilyName>Johnson</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>CB</Initials>
                    <FamilyName>Read</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Encyclopedia of Statistical Sciences Volume 4</BookTitle>
                  <PublisherName>Wiley</PublisherName>
                  <PublisherLocation>New York</PublisherLocation>
                  <FirstPage>150</FirstPage>
                  <LastPage>153</LastPage>
                </BibChapter>
                <BibUnstructured>Hausman JA. Instrumental variable estimation. In: Kotz, S, Johnson NI, Read CB, eds.<Emphasis Type="Italic">Encyclopedia of Statistical Sciences Volume 4</Emphasis>. New York: Wiley, 1983;150–153.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Newhouse</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>McClellan</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Econometrics in outcomes research: the use of instrumental variables</ArticleTitle>
                  <JournalTitle>Annu Rev Public Health.</JournalTitle>
                  <VolumeID>19</VolumeID>
                  <FirstPage>17</FirstPage>
                  <LastPage>34</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9611610</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1146/annurev.publhealth.19.1.17</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1c3nsVGntg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables.<Emphasis Type="Italic">Annu Rev Public Health.</Emphasis> 1998;19:17–34.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Amemiya</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ChapterTitle Language="En">Two-stage least squares</ChapterTitle>
                  <BibEditorName>
                    <Initials>S</Initials>
                    <FamilyName>Kotz</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>NI</Initials>
                    <FamilyName>Johnson</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>CB</Initials>
                    <FamilyName>Read</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Encyclopedia of Statistical Sciences Volume 9</BookTitle>
                  <PublisherName>Wiley</PublisherName>
                  <PublisherLocation>New York</PublisherLocation>
                  <FirstPage>373</FirstPage>
                  <LastPage>375</LastPage>
                </BibChapter>
                <BibUnstructured>Amemiya T. Two-stage least squares. In: Kotz S, Johnson NI, Read CB, eds.<Emphasis Type="Italic">Encyclopedia of Statistical Sciences Volume 9</Emphasis>. New York: Wiley, 1988;373–375.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibUnstructured>SAS Institute Inc. SAS/ETS Users Guide. SAS Online Doc. Version 8. 1999.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Pearl</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <BookTitle>Causality</BookTitle>
                  <PublisherName>Cambridge University Press</PublisherName>
                  <PublisherLocation>Cambridge, United Kingdom</PublisherLocation>
                </BibBook>
                <BibUnstructured>Pearl J. Causality. Cambridge, United Kingdom: Cambridge University Press, 2000.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Little</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DB</Initials>
                    <FamilyName>Rubin</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches</ArticleTitle>
                  <JournalTitle>Annu Rev Public Health.</JournalTitle>
                  <VolumeID>21</VolumeID>
                  <FirstPage>121</FirstPage>
                  <LastPage>145</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10884949</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1146/annurev.publhealth.21.1.121</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3M%2FhsVCktg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Little RJ, Rubin DB. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches.<Emphasis Type="Italic">Annu Rev Public Health.</Emphasis> 2000;21:121–145.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Greenland</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Robins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Pearl</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Confounding and collapsibility in causal inference</ArticleTitle>
                  <JournalTitle>Stat Sci.</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>29</FirstPage>
                  <LastPage>46</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1214/ss/1009211805</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Greenland S, Robins JM, Pearl J. Confounding and collapsibility in causal inference.<Emphasis Type="Italic">Stat Sci.</Emphasis> 1999;14:29–46.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Angrist</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GW</Initials>
                    <FamilyName>Imbens</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DB</Initials>
                    <FamilyName>Rubin</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Identification of causal effects using instrumental variables (with discussion)</ArticleTitle>
                  <JournalTitle>J Am Stat Assn.</JournalTitle>
                  <VolumeID>434</VolumeID>
                  <FirstPage>444</FirstPage>
                  <LastPage>472</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.2307/2291629</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables (with discussion).<Emphasis Type="Italic">J Am Stat Assn.</Emphasis> 1996;434:444–472.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
